KMDAのチャート
KMDAの企業情報
| symbol | KMDA |
|---|---|
| 会社名 | Kamada Ltd （カマダ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | ― 医療関連（Health Care） |
| 概要 | 事業概要 -- カマダは、イスラエルのバイオ医薬品企業。希少薬に焦点を当て、血漿由来タンパク質の治療薬の開発、製造を手掛ける。おもに米国とヨ―ロッパにおいて戦略的パ―トナ―や現地代理店を通じて、または直接販売にて治療薬を提供するほか、新興市場向けに販売を行う。主力製品としてGlassiaを提供する。 kamada ltd. is focused on plasma-derived protein therapeutics for orphan indications, and has a commercial product portfolio and a robust late-stage product pipeline. the company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce alpha-1 antitrypsin (aat) in a highly-purified, liquid form, as well as other plasma-derived proteins. aat is a protein derived from human plasma with known and newly-discovered therapeutic roles given its immunomodulatory, anti-inflammatory, tissue-protective and antimicrobial properties. the company’s flagship product is glassia®, the first and only liquid, ready-to-use, intravenous plasma-derived aat product approved by the u.s. food and drug administration. kamada markets glassia in the u.s. through a strategic partnership with baxter international. in addition to glassia, kamada has a product line of nine other pharmaceutical products that are marketed through distributor |
| 本社所在地 | 2 Holzman St. Weizmann Science Park Rehovot 7670402 ISR |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | ― |
| 設立年月日 | 1990年 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2013年 |
| 従業員数 | 413人 |
| url | www.kamada.com |
| nasdaq_url | https://www.nasdaq.com/symbol/kmda |
| adr_tso | ― |
| EBITDA | EBITDA ー |
| 終値（lastsale） | 6.1027 |
| 時価総額（marketcap） | 245740637.0229 |
| 時価総額 | 時価総額 ― |
| 売上高 | 売上高 -- |
| 企業価値(EV) | 企業価値(EV) ー |
| 当期純利益 | 当期純利益 -- |
| 決算概要 | 決算概要 -- |
KMDAのテクニカル分析
KMDAのニュース
Kamada Ltd. (KMDA) Q1 2023 Earnings Call Transcript 2023/05/24 17:21:02 Seeking Alpha
Kamada Ltd. (NASDAQ:NASDAQ:KMDA) Q1 2023 Results Earnings Conference Call May 24, 2023 8:30 AM ETCompany ParticipantsBrian Ritchie - Investor Relations, LifeSci Advisors, LLCAmir London -…
Why America''s Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday''s Mid-Day Session 2023/05/24 16:48:08 Benzinga
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS ) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods. EpicQuest Education Group International Limited (NASDAQ: EEIQ ) shares surged 88.4% to $2.75 after gaining 8% on Tuesday. EpicQuest Education''s Davis College signed a non-binding Memorandum of Understanding with Chongqing College of Electronic Engineering. Enveric Biosciences, Inc. (NASDAQ: ENVB ) jumped 85% to $5.83 after the company announced it received a Notice of Allowance from the USPTO for a patent application involving its EVM201 Series. GigaCloud Technology Inc. (NASDAQ: GCT ) shares climbed 62.2% to $9.31 after the company reported a year-over-year increase in first-quarter financial results. Zura Bio Limited (NASDAQ: ZURA ) shares gained 36% to $7.28 after Raymond James initiated coverage on the stock with a Strong Buy rating and a $20 price target. Apexigen, Inc. (NASDAQ: APGN ) gained 31% to $0.5235 after Pyxis Oncology announced it will acquire the company.
FIMI Opportunity to take ~38% stake in Kamada with $60M stock buy 2023/05/24 16:10:27 Seeking Alpha
Kamada (KMDA) stock rose after the company said private equity firm FIMI Opportunity Funds will buy $60M worth of its ordinary shares. Read more here
Kamada: Q1 Earnings Snapshot 2023/05/24 11:20:52 WTOP
REHOVOT, Israel (AP) — REHOVOT, Israel (AP) — Kamada Ltd. (KMDA) on Wednesday reported a loss of $1.8 million in…
Kamada: Q1 Earnings Insights 2023/05/24 11:20:11 Benzinga
Kamada (NASDAQ: KMDA ) reported its Q1 earnings results on Wednesday, May 24, 2023 at 07:10 AM. Here''s what investors need to know about the announcement. Earnings Kamada missed estimated earnings by 300.0%, reporting an EPS … Full story available on Benzinga.com
Kamada Ltd.''s (KMDA) CEO Amir London On Q4 2021 Results - Earnings Call Transcript 2022/03/15 13:48:08 Seeking Alpha
Kamada GAAP EPS of -$0.11 misses by $0.10, revenue of $31.47M beats by $9.56M 2022/03/15 11:08:13 Seeking Alpha
Kamada press release (KMDA): Q4 GAAP EPS of -$0.11 misses by $0.10.Revenue of $31.47M (-0.1% Y/Y) beats by $9.56M.
Kamada Q4 2021 Earnings Preview (NASDAQ:KMDA) 2022/03/14 16:49:07 Seeking Alpha
Kamada (NASDAQ:KMDA) is scheduled to announce Q4 earnings results on Tuesday, March 15th, before market open.The consensus EPS Estimate is -$0.01 and the consensus Revenue Estimate…
$23.37 Million in Sales Expected for Kamada Ltd. (NASDAQ:KMDA) This Quarter 2021/12/14 01:30:42 Transcript Daily
Wall Street brokerages forecast that Kamada Ltd. (NASDAQ:KMDA) will report sales of $23.37 million for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Kamada’s earnings. The lowest sales estimate is $22.24 million and the highest is $24.50 million. Kamada reported sales of $31.54 million during the same quarter last […]
Analysts Anticipate Kamada Ltd. (NASDAQ:KMDA) to Post $0.02 Earnings Per Share 2021/12/09 14:54:47 Dakota Financial News
Equities analysts expect that Kamada Ltd. (NASDAQ:KMDA) will announce $0.02 earnings per share for the current quarter, according to Zacks. Two analysts have issued estimates for Kamadas earnings. The highest EPS estimate is $0.04 and the lowest is ($0.01). Kamada reported earnings of $0.04 per share in the same quarter last year, which suggests a []
Kamada to Announce Second Quarter and First Half 2021 Financial Results and Host Conference Call on August 11, 2021 2021/08/05 11:00:00 Intrado Digital Media
REHOVOT, Israel, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived biopharmaceutical company, today announced that it will release financial results for the three and six months ended June 30, 2021, prior to the open of the U.S. financial markets on Wednesday, August 11, 2021.
Former judge who told friend of drug investigation sentenced 2021/07/29 22:35:29 Albuquerque Journal
DENVER A former Weld County District Judge who tipped off a friend that a mutual acquaintance was the target of a federal drug investigation has been sentenced to a year and a day in prison. U.S. District Court Judge William Martinez sentenced 42-year-old Ryan Kamada on Wednesday, The Greeley Tribune reported. Kamada was also []
Rabies Immunoglobulin Market Size Competitive Strategies & Forecasts Research Report 2021-2028 Sanofi, Shanghai RAAS, KEDRAB, Bharat Serum, Kamada 2021/07/27 07:16:01 OpenPR
Rabies is a zoonotic viral disease caused due to animal bites. The disease is mainly transmitted from domestic and wild animals such as bats, foxes, racc, cats, or dogs and infects humans upon contacting infected animal saliva. Its incubation period
Alpha-1 Antitrypsin Drugs Market 2021 SWOT Analysis, Competitive Landscape and Significant Growth | Top Brands:Baxter, Arrowhead Research Corporation, Kamada, CSL Behring, Applied Genetic Technolog 2021/07/24 13:06:43 Jumbo News
This report studies the Alpha-1 Antitrypsin Drugs Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Alpha-1 Antitrypsin Drugs market segmented by company, []
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street 2021/07/20 12:19:55 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated (NASDAQ: CYTK ) ( announced topline results from Cohorts 1 and 2 of the Phase 2 study of CK-274 in obstructive outflow disease in hypertrophic cardiomyopathy) Forward Pharma A/S (NASDAQ: FWP ) ResMed Inc. (NYSE: NRMD) Legend Biotech Corporation (NASDAQ: LEGN ) Moderna, Inc. (NASDAQ: MRNA ) ( extended gains on recent momentum) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 19) 4D pharma plc (NASDAQ: LBPS ) Adaptimmune Therapeutics plc (NASDAQ: ADAP ) Adverum Biotechnologies, Inc. (NASDAQ: ADVM ) Aerovate Therapeutics, Inc. (NASDAQ: AVTE ) (IPOed June 30) Agile Therapeutics, Inc. (NASDAQ: AGRX ) Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ) Alzamend Neuro, Inc. (NASDAQ: ALZN ) Aptose Biosciences Inc. (NASDAQ: APTO ) ARCA biopharma, Inc. (NASDAQ: ABIO ) Ascendis Pharma A/S (NASDAQ: ASND ) Assembly Biosciences, Inc.